CHRU Brest
CHRU Brest
Brest, France21 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Efficacy and Safety of BUFY02 Versus TRB02 in the Treatment of Dry Eye Disease | dry eye syndrome, eye disorder, lacrimal apparatus disorder | Recruiting | Not applicable | 2026-09-29 | NCT05865457 | |
| Comparison of Two Antibiotic Regimens for the Treatment of Early Airways Infection With PA in Adults With Bronchiectasis | bronchial disorder, bronchiectasis, respiratory system disorder | Recruiting | Phase 2 | 2026-08-27 | NCT06368804 | |
| Phase II Study Evaluating Safety and Efficacy of Tislelizumab for Elderly Patients Unfit for Chemotherapy, With Advanced Esophageal Squamous-cell Carcinoma | Digestive System Diseases, Digestive System Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, carcinoma, digestive system disorder, digestive system neoplasm, epithelial neoplasm, esophageal disorder, esophageal squamous cell carcinoma, neoplasm, squamous cell carcinoma, squamous cell neoplasm | Recruiting | Phase 2 | 2026-05-20 | NCT07205731 | |
| Efficiency of a Composite Personalised Care on Functional Outcome in Early Psychosis | Psychotic Disorders, Schizophrenia Spectrum and Other Psychotic Disorders, psychiatric disorder | Recruiting | Phase 3 | 2026-04-20 | NCT05796401 | |
| Amoxicillin Alone Versus Amoxicillin/Clavulanate for Community-acquired Pneumonia in Patients Aged 65 Years or Older, and Hospitalized in a Non-intensive Care Unit Ward | Community-Acquired Infections, Community-Acquired Pneumonia, Infections, pneumonia, respiratory system disorder, respiratory tract infectious disorder | Recruiting | Phase 3 | 2026-04-08 | NCT06229288 | |
| Clonal Architecture of ASXL1-mutated Myelofibrosis | Hemic and Lymphatic Diseases, Myeloproliferative Disorders, bone marrow disorder, hematologic disorder, primary myelofibrosis | Recruiting | Not applicable | 2026-03-09 | NCT05710211 | |
| Quality of Care in French HIV Infected Patients | AIDS, Blood-Borne Infections, Digestive System Diseases, Flaviviridae infectious disease, Genital Diseases, HIV infectious disease, Infections, RNA Virus Infections, Slow Virus Diseases, Urogenital Diseases, hepatitis, hepatitis C virus infection, immune system disorder, inborn error of immunity, infectious disease, lentivirus infection, liver disorder, sexually transmitted disease, uterine carcinosarcoma, viral hepatitis, viral infectious disease, viral sexually transmitted disease | Recruiting | Not stated | 2026-02-20 | NCT02898987 | |
| Cognitive and Metacognitive Remediation in Addiction Treatment. | Alcohol Use Disorder, Chemically-Induced Disorders, alcohol-related disorders, psychiatric disorder, substance-related disorder | Not yet recruiting | Not applicable | 2026-02-19 | NCT07390877 | |
| Dat'Aids Prevention | HIV Prevention | Recruiting | Not stated | 2026-01-15 | NCT03795376 | |
| Multicentre Study of MITRACLIP® Transcatheter Mitral Valve Repair in Patients With Severe Primary Mitral Regurgitation Eligible for High-risk Surgery | cardiovascular disorder, heart disorder, heart valve disorder, mitral valve insufficiency | Active, not recruiting | Not applicable | 2025-11-26 | NCT03271762 | |
| Consolidative Radiotherapy for Metastatic Urothelial Bladder Cancer Patients Without Progression and With no More Than Three Residual Metastatic Lesions Following First Line Systemic Therapy | Urothelial Bladder Cancer | Recruiting | Phase 2 | 2025-11-18 | NCT04428554 | |
| Safety and Efficacy of Ponatinib Followed by Imatinib in Patients With Chronic Myelogenous Leukemia in Chronic Phase | Chronic Disease, Disease Attributes, Hemic and Lymphatic Diseases, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Myeloproliferative Disorders, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, bone marrow disorder, chronic myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm | Active, not recruiting | Phase 2 | 2025-11-18 | NCT04070443 | |
| Constitution of a Prospective Cohort of Patients With Acute Suppurative Hidrosadenitis Followed in the Great West: the COVER Cohort (Verneuil Cohort) | Acute Hidrosadenitis | Recruiting | Not stated | 2025-09-05 | NCT04352036 | |
| Developmental and Epileptic Encephalopathy of Genetic Etiology: Natural History Through Reuse of Clinical Data | developmental and epileptic encephalopathy | Recruiting | Not stated | 2025-06-29 | NCT06380192 | |
| Observational Study in Patients Treated With JAK Inhibitors for Inflammatory Rheumatism (MAJIK) | Bacterial Infections and Mycoses, Infections, Skin Diseases, Papulosquamous, Skin and Connective Tissue Diseases, Spondylarthritis, Spondylarthropathies, arthritic joint disease, arthropathy, autoimmune disease, bacterial infectious disease, bone disorder, connective tissue disorder, gram-positive bacterial infections, immune system disorder, musculoskeletal system disorder, psoriasis, psoriatic arthritis, rheumatic disorder, rheumatic fever, rheumatoid arthritis, skin disorder, spondylitis, spondyloarthropathy, streptococcal infection, vertebral column disorder | Active, not recruiting | Not stated | 2025-01-23 | NCT04602091 | |
| Observatory of Patients With Haemophilia B Treated by IdElvion® | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, X-linked disease, blood coagulation disease, coagulation protein disease, hematologic disorder, hemophilia B, hemorrhagic disease, hereditary disease, inherited blood coagulation disorder | Active, not recruiting | Not stated | 2025-01-08 | NCT05086575 | |
| Hizentra® in Inflammatory Neuropathies - pHeNIx Study | Chronic Disease, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, autoimmune disease, autoimmune disorder of the nervous system, chronic inflammatory demyelinating polyradiculoneuropathy, demyelinating disease, immune system disorder, nervous system disorder, neuromuscular disease, peripheral nervous system disorder, polyneuropathy, polyradiculoneuropathy | Recruiting | Not stated | 2025-01-07 | NCT04672733 | |
| Standard of Care +/- 177Lu-PSMA-617 In de Novo mHSPC Patients With Poor PSA Response (PEACE6-Poor Responders) | Genital Diseases, Male Urogenital Diseases, Urogenital Diseases, male reproductive system disorder, metastatic prostate carcinoma, prostate disorder | Recruiting | Phase 3 | 2024-12-20 | NCT06496581 | |
| Predictive Signature of Benralizumab Response | Eosinophilia, Hemic and Lymphatic Diseases, Hypersensitivity, Immediate, Respiratory Hypersensitivity, asthma, bronchial disorder, hematologic disorder, hypereosinophilic syndrome, immune system disorder, leukocyte disorder, lung disorder, obstructive lung disease, pulmonary eosinophilia, respiratory system disorder | Recruiting | Phase 4 | 2024-04-26 | NCT04565483 | |
| Juvenile Inflammatory Rheumatism (JIR) Cohorte | Skin and Connective Tissue Diseases, arthritic joint disease, arthropathy, autoimmune disease, connective tissue disorder, immune system disorder, juvenile idiopathic arthritis, musculoskeletal system disorder, rheumatic disorder | Enrolling by invitation | Not stated | 2023-06-15 | NCT02377245 | |
| Rifabutin Versus Rifampicin for Treatment of Staphylococcal PJI Treated With DAIR | Prosthetic Infection | Recruiting | Phase 3 | 2022-05-10 | NCT04672525 |